Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Medical Centre Ljubljana
Age
20–50
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Female sex
Age between 18 and 50 years
BMI between 30 kg/m² and 40 kg/m² at pre-screening
Prior comprehensive non-pharmacological and non-surgical management of obesity, including a history of at least 12 months of intensive lifestyle intervention with a maximum weight reduction of less than 5%
Stable body weight within the three months preceding study enrollment (defined as weight fluctuations within 5%)
No prior pharmacological or surgical interventions for obesity
Euthyroid state
Eumenorrhea or Oligomenorrhea
Ability to comprehend the study objectives and procedures
Willingness to provide informed consent and to comply with the study protocol, including the use of highly effective contraception during the study period, with signed consent and agreement provided in duplicate
Commitment to use highly reliable contraception and absence of plans for pregnancy within the 8 months following enrollment
You may not be if
Pregnancy or lactation
Postmenopausal
Amenorea
Type 2 diabetes
Reliance on natural contraception methods
Non-compliance with previous therapeutic regimens
Personal history of malignancy
Personal or family history of medullary thyroid carcinoma
Personal history of pancreatitis
Personal history of cholelithiasis
Personal history of major depressive episodes or suicidal ideation
Personal history of acute coronary events or hemodynamically significant coronary artery disease
Psychiatric disorders
Current treatment with sympathomimetics or sympatholytics
Excessive alcohol consumption
Clareo Health | Effect of Tirzepatide on Brown Adipose Tissue in Obesity
